Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular...
SCAI
This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies.
-
-
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial...
-
All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been...
-
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework for ethically and safely...
Videos | Cath Lab | February 04, 2021
Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular Angiography and Interventions (SCAI), and...
Getty Images
News | Coronavirus (COVID-19) | October 14, 2020
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction...
A panel discussion with some of the key opinion leaders at the recent SCCT 2020 virtual meeting. Note the questions on the left side of the screen, where attendees were able to interact with the speakers.
News | Cardiovascular Education | August 14, 2020 | Dave Fornell, Editor
All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been apprehension...
At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle and a still micropunture sheath. Photo and slides courtesy of Yader Sandoval, M.D.
Feature | Vascular Access | June 10, 2020 | Dave Fornell, Editor
Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access...
Feature | Cardiovascular Business | June 03, 2020
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework...
Feature | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still...
Feature | SCAI | May 21, 2020
May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the...
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.
News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were...
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or...
News | SCAI | May 17, 2020
May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery...
News | May 17, 2020
May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to...
Icosapent Ethyl (Vascepa) significantly reduces revascularizations in statin patients based on data from the REDUCE-IT REVASC analyses, presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell
News | Pharmaceuticals | May 17, 2020
May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy....
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration.
News | Stents | May 17, 2020
May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP)...
News | SCAI | May 17, 2020
May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary...
The protocol chart for the LATIN STEMI telecardiology program.
News | Telecardiology | May 15, 2020
May 15, 2020 – A groundbreaking trial recently examined the viability of telemedicine for remote guidance of a...
